Asylia Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Asylia Therapeutics's estimated annual revenue is currently $310k per year.
- Asylia Therapeutics's estimated revenue per employee is $77,500
- Asylia Therapeutics's total funding is $22.7M.
Employee Data
- Asylia Therapeutics has 4 Employees.
- Asylia Therapeutics grew their employee count by 100% last year.
Asylia Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Senior Principal Scientist | Reveal Email/Phone |
Asylia Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.7M | 11 | -8% | N/A | N/A |
#2 | $14.9M | 96 | -6% | N/A | N/A |
#3 | $15.2M | 98 | 3% | $1.8M | N/A |
#4 | $1.6M | 10 | 0% | N/A | N/A |
#5 | $3.4M | 22 | 0% | N/A | N/A |
#6 | $2.8M | 18 | 50% | N/A | N/A |
#7 | $7.4M | 48 | -2% | N/A | N/A |
#8 | $0.8M | 5 | 0% | N/A | N/A |
#9 | $1.6M | 10 | 0% | N/A | N/A |
#10 | $16.3M | 105 | 62% | N/A | N/A |
What Is Asylia Therapeutics?
Asylia Therapeutics, established August 6, 2019, is a private, development-stage biotechnology company advancing novel immune modulating therapies for cancer and autoimmune diseases, which collectively impact millions of Americans annually. The company’s platform centers on a drug pipeline capable of modulating antigen presentation to the immune system which has, to date, produced remarkable anti-tumor responses across a spectrum of well established cancer models.
keywords:N/A
$22.7M
Total Funding
4
Number of Employees
$310k
Revenue (est)
100%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Houston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.5M | 4 | 0% | N/A |
#2 | $0.7M | 4 | -83% | N/A |
#3 | $0.3M | 4 | N/A | N/A |
#4 | $0.4M | 4 | N/A | N/A |
#5 | $0.4M | 4 | N/A | N/A |